News
AbbVie is investing $195m to strengthen domestic API production, with the expansion of its manufacturing plant in North ...
Construction on the site will begin in the fall and is expected to be finished by 2027. North Chicago is already home to ...
AbbVie to invest $195m in US API manufacturing expansion as pharma rushes to boost domestic capacity ahead of expected drug ...
AbbVie Inc.'s Q2 2025 results showcase Skyrizi & Rinvoq's growth, strong finances, and a promising pipeline. Click for my ...
11h
WQRF Rockford on MSNIllinois secures AbbVie’s $195 million investment for North Chicago facility
AbbVie, the maker of Botox, Humira, and Rinvoq, will invest $195 million to expand its North Chicago manufacturing facility, ...
AbbVie, a global leader in life sciences, announced Tuesday the company’s is investing $195 million to expand its North ...
NORTH CHICAGO Governor JB Pritzker, AbbVie, and the Illinois Department of Commerce and Economic Opportunity (DCEO) today ...
15h
TipRanks on MSNAbbVie announces $195M investment to expand API manufacturing in U.S.
AbbVie (ABBV) announced a $195M investment in its North Chicago, Illinois manufacturing plant to expand domestic active ...
Governor JB Pritzker, AbbVie, and the Illinois Department of Commerce and Economic Opportunity (DCEO) have announced a ...
As pharma companies big and small play up their U.S. investment plans during the second Trump administration, the particulars ...
17h
TipRanks on MSNAbbVie’s Promising Study on ABBV-453 for Multiple Myeloma: What Investors Need to Know
Abbvie (($CC:ABBV.CUR)) announced an update on their ongoing clinical study. AbbVie is currently conducting a clinical study ...
AbbVie said on Thursday its tariff exposure is not expected to exceed that of rivals, and raised its 2025 profit forecast ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results